Metabolic profile in women with polycystic ovary syndrome across adult life
Artículo
Open/ Download
Publication date
2016Metadata
Show full item record
Cómo citar
Echiburú López, Bárbara
Cómo citar
Metabolic profile in women with polycystic ovary syndrome across adult life
Author
Abstract
Objective. To assess insulin sensitivity, insulin secretion and metabolic profile in women with polycystic ovary syndrome (PCOS) in different stages of reproductive life.
Materials and methods. In a cross-sectional study, 190 PCOS women (PCOSw) and 99 controls (Cw) aged between 18 and 55 years were included. PCOSw and Cw were distributed into 3 stages of reproductive life: early reproductive age (18-34 years old), late reproductive age (35-40 years old) and perimenopausal period (41-55 years old). Waist circumference (WC), body mass index (BMI) and blood pressure (BP) were recorded. An oral glucose tolerance test (OGTT) with measurement of glucose and insulin was performed. Sex steroids and lipid profile were also determined in the fasting sample. Insulin sensitivity was assessed by HOMA-IR and ISI composite, and insulin secretion by HOMA-beta and insulinogenic index. Visceral adiposity index (VAI) and lipid accumulation product (LAP) were also calculated. Metabolic syndrome (MS) was assessed by the IDF and ATPIII criteria.
Results. At early reproductive age, PCOSw showed higher BMI, WC, and VAI and a higher prevalence of MS compared to Cw (p < 0.05). In addition, at late reproductive age PCOSw also showed elevated total cholesterol, triglycerides, insulin secretion, LAP and BP. At perimenopausal period, these parameters were not different between Cw and PCOSw. Within the PCOSw group, HOMA-beta was lower at late reproductive and perimenopausal periods compared to the early reproductive age. Regarding control women, a deterioration of anthropometric and metabolic parameters was observed in perimenopausal women compared to early and late reproductive women.
Conclusions. Our results suggest that metabolic derangements associated with PCOS are more evident at the early and late reproductive ages. On the other hand, during perimenopause, there is no further deterioration of metabolic parameters. Nevertheless, a disruption in pancreatic 3-cell function is evidenced at this stage.
Patrocinador
Fondo Nacional de Desarrollo Cientifico y Tecnologico (National Fund for Scientific and Technological Research; Fondecyt) 1,110,864
SOCHED (Chilean Society of Endocrinology and Diabetes) 2009-48 05
Indexation
Artículo de publicación ISI Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/140368
DOI: 10.1016/j.metabol.2016.01.006
ISSN: 1532-8600
Quote Item
Metabolism Volume 65, Issue 5, May 2016, Pages 776–782
Collections
The following license files are associated with this item: